alpha-aminopyridine has been researched along with Brill-Symmers Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Arenas, F; Balagué, O; Campo, E; Capdevila, C; Carreras, J; Cid, MC; Colomer, D; Guerrero-Hernández, M; Hernández, L; López-Guillermo, A; Magnano, L; Martin, S; Matas-Céspedes, A; Pérez-Galán, P; Rivas-Delgado, A; Rodriguez, V; Serrat, N; Tannheimer, S; Valero, JG; Yahiaoui, A | 1 |
| Barca, EG; Barrigon, DC; Bociek, RG; Gerecitano, J; Kim, WS; Kong, O; Martinelli, G; Pisal, CB; Salles, G; Tavorath, R; Turgut, M; Younes, A | 1 |
| Balsas, P; Campo, E; Casserras, T; Colomer, D; Giné, E; Kalko, SG; López-Guillermo, A; Matas-Céspedes, A; Pérez-Galán, P; Rodriguez, V; Rosich, L; Roué, G; Vidal-Crespo, A; Villamor, N | 1 |
1 trial(s) available for alpha-aminopyridine and Brill-Symmers Disease
| Article | Year |
|---|---|
Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Aminopyridines; Female; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Recurrence; Remission Induction; Salvage Therapy | 2017 |
2 other study(ies) available for alpha-aminopyridine and Brill-Symmers Disease
| Article | Year |
|---|---|
The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma.
Topics: Aminopyridines; Animals; Apoptosis; Biomarkers, Tumor; Cell Differentiation; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Follicular; Macrophages; Mice; Monocytes; Phosphorylation; Pyrroles; Receptor, Macrophage Colony-Stimulating Factor; Tumor Cells, Cultured; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2021 |
Disruption of follicular dendritic cells-follicular lymphoma cross-talk by the pan-PI3K inhibitor BKM120 (Buparlisib).
Topics: Aminopyridines; Animals; Cell Adhesion; Cell Communication; Cell Line, Tumor; Cell Movement; Cell Survival; Chemokine CXCL12; Cluster Analysis; Dendritic Cells, Follicular; Disease Models, Animal; Extracellular Matrix; Gene Expression Profiling; Humans; Lymphoma, Follicular; Mice; Morpholines; Neovascularization, Pathologic; Phosphoinositide-3 Kinase Inhibitors; Receptors, CXCR4; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |